Basilea Pharmaceutica AG

BPMUF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$16$57$21-$21
Dep. & Amort.$1$1$1$2
Deferred Tax$0$0$0$3
Stock-Based Comp.$3$3$3$1
Change in WC$2$8$1$9
Other Non-Cash$1-$12-$8-$1
Operating Cash Flow$23$56$18-$8
Investing Activities
PP&E Inv.-$0-$1-$0-$1
Net Acquisitions$0$1$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0-$1$1$0
Investing Cash Flow-$0-$1$0-$1
Financing Activities
Debt Repay.$0-$16-$16$0
Stock Issued$0-$2$5$1
Stock Repurch.$0$0$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$14$13$2-$40
Financing Cash Flow-$14-$0-$13-$40
Forex Effect-$0-$0$0-$0
Net Chg. in Cash$133$55$57-$78
Supplemental Information
Beg. Cash$0$69$12$91
End Cash$133$125$69$12
Free Cash Flow$23$55$17-$8